Leaflet PLEGOMAZIN 25mg / 5ml solution for injection


Indicated for: schizophrenia; bipolar disorder

Route of administration: injectable

Substance: chlorpromazine (antipsychotic)

ATC: N05AA01 (Nervous system | Antipsychotics | Phenothiazines with aliphatic side-chain)

Chlorpromazine is a phenothiazine antipsychotic used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions. It is also used to relieve severe nausea and vomiting.

The medication is administered orally, intramuscularly, or intravenously, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as drowsiness, dizziness, or dry mouth. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, dizziness, dry mouth, and constipation. In rare cases, severe reactions such as neuroleptic malignant syndrome or tardive dyskinesia may occur. Patients should be informed of these risks before starting treatment.

General data about PLEGOMAZIN 25mg / 5ml

  • Substance: chlorpromazine
  • Date of last drug list: 01-07-2013
  • Commercial code: W07612001
  • Concentration: 25mg / 5ml
  • Pharmaceutical form: solution for injection
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).